Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Multi Units Luxembourg SICAV - Amundi MSCI EMU Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €62.61 |
52 Week High | €64.00 |
52 Week Low | €55.77 |
Beta | 0 |
1 Month Change | -1.36% |
3 Month Change | 6.21% |
1 Year Change | 10.64% |
3 Year Change | 13.10% |
5 Year Change | 32.87% |
Change since IPO | 26.84% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LYMFE | CH Capital Markets | CH Market | |
---|---|---|---|
7D | -0.7% | -0.1% | -0.4% |
1Y | 10.6% | 30.1% | -4.5% |
Return vs Industry: LYMFE underperformed the Swiss Capital Markets industry which returned 31.7% over the past year.
Return vs Market: LYMFE exceeded the Swiss Market which returned -4.2% over the past year.
Price Volatility
LYMFE volatility | |
---|---|
LYMFE Average Weekly Movement | 1.2% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 3.6% |
10% most volatile stocks in CH Market | 7.4% |
10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: LYMFE has not had significant price volatility in the past 3 months.
Volatility Over Time: LYMFE's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | n/a |
Multi Units Luxembourg SICAV - Amundi MSCI EMU Fundamentals Summary
LYMFE fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LYMFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LYMFE income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LYMFE perform over the long term?
See historical performance and comparison